Evidence map›Paper›PMID 33986734›Full record

ArticleFrontiers in microbiology2021

Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion.

Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Satoko Matsunaga, Mayuko Nishi, Ayumi Kudoh, Akinori Takaoka, Tatsuya Sawasaki, Akihide Ryo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sundararaj Stanleyraj JeremiahDepartment of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan.
Kei MiyakawaDepartment of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan.
Satoko MatsunagaDepartment of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan.
Mayuko NishiDepartment of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan.
Ayumi KudohDepartment of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan.
Akinori TakaokaDivision of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Tatsuya SawasakiDivision of Cell-Free Life Science, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Akihide RyoDepartment of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan.
Yokohama City University · JPEhime University · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type-I interferons (IFN-I) are the innate immune system's principal defense against viral infections. Human immunodeficiency virus-1 (HIV-1) has evolved several ways to suppress or evade the host's innate immunity in order to survive and replicate to sustain infection. Suppression of IFN-I is one among the multiple escape strategies used by HIV-1 to prevent its clearance. HIV-1 protease which helps in viral maturation has also been observed to cleave host cellular protein kinases. In this study we performed a comprehensive screening of a human kinase library using AlphaScreen assay and identified that TANK binding kinase-1 (TBK1) was cleaved by HIV-1 protease (PR). We demonstrate that PR cleaved TBK1 fails to phosphorylate IFN regulatory factor 3 (IRF3), thereby reducing the IFN-I promoter activity and further reveal that the PR mediated suppression of IFN-I could be counteracted by protease inhibitors (PI)

Indexed as

HIV-1 proteaseimmune evasionpathogenic fitnessTANK binding kinase-1type-I interferon

Identifiers

PMID33986734
PMCPMC8110901
OpenAlexW3158118087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.